TNF and inflammatory bowel disease: Although targeting deregulated autophagy, such as through anti-TNF, is considered effective at inducing and maintaining clinical remission, agents that directly promote autophagy have yet to be clinically tested as monotherapy or in combination with existing therapies in IBD.